# Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial

> **NCT04330690** · PHASE3 · UNKNOWN · sponsor: **Sunnybrook Health Sciences Centre** · enrollment: 2900 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Artesunate
- **DRUG:** Imatinib
- **DRUG:** Infliximab
- **DRUG:** Dexamethasone
- **DRUG:** LSALT Peptide

## Key facts

- **NCT ID:** NCT04330690
- **Lead sponsor:** Sunnybrook Health Sciences Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-18
- **Primary completion:** 2024-03-10
- **Final completion:** 2024-05-18
- **Target enrollment:** 2900 (ESTIMATED)
- **Last updated:** 2023-10-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04330690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04330690, "Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04330690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*